We are live on
!
Find out more
1CM
1492 Capital Management Portfolio holdings
AUM
$263M
1-Year Est. Return
61.9%
This Fund
S&P 500
This Quarter
Est. Return
+59.55%
1 Year Est. Return
+61.9%
3 Year Est. Return
+187.15%
5 Year Est. Return
+242.53%
10 Year Est. Return
+2,731.07%
AUM
$117M
AUM Growth
+$33.2M
(+40%)
Cap. Flow
+$3.46M
Cap. Flow
% of AUM
2.97%
Top 10 Holdings %
Top 10 Hldgs %
41.87%
Holding
99
New
19
Increased
13
Reduced
46
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ROCHU
Roth CH Acquisition I Co. Unit
ROCHU
|
+$2.14M |
| 2 |
Designer Brands
DBI
|
+$1.27M |
| 3 |
BMCH
BMC Stock Holdings, Inc
BMCH
|
+$1.2M |
| 4 |
Darling Ingredients
DAR
|
+$1.18M |
| 5 |
Encompass Health
EHC
|
+$1.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KB Home
KBH
|
+$1.22M |
| 2 |
Powell Industries
POWL
|
+$1.07M |
| 3 |
NeoGenomics
NEO
|
+$1.06M |
| 4 |
DOC
PHYSICIANS REALTY TRUST
DOC
|
+$863K |
| 5 |
SPNS
Sapiens International
SPNS
|
+$861K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.38% |
| 2 | Healthcare | 22.68% |
| 3 | Consumer Discretionary | 17.13% |
| 4 | Industrials | 6.25% |
| 5 | Financials | 6.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Methode Electronics
MEI
$612M
| $1.4M | 1.2% |
44,678
+170
| +0.4% | +$5.1K |
|
|
BMCH
27
DELISTED
BMC Stock Holdings, Inc
BMCH
| $1.36M | 1.17% |
+54,148
| New | +$1.2M |
|
|
28
Darling Ingredients
DAR
$9.19B
| $1.34M | 1.15% |
+54,337
| New | +$1.18M |
|
29
Collegium Pharmaceutical
COLL
$1.16B
| $1.33M | 1.14% |
75,988
+36,997
| +95% | +$724K |
|
|
MAGN
30
Magnera Corp
MAGN
$482M
| $1.25M | 1.07% |
5,990
+1,413
| +31% | +$268K |
|
31
Tactile Systems Technology
TCMD
$676M
| $1.22M | 1.04% |
29,450
-4
| -0% | -$187 |
|
|
SYNH
32
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $1.18M | 1.01% |
20,324
-99
| -0.5% | -$5.32K |
|
|
WNS
33
DELISTED
WNS Holdings
WNS
| $1.09M | 0.93% |
19,774
-64
| -0.3% | -$3.06K |
|
34
iShares Biotechnology ETF
IBB
$9.47B
| $1.07M | 0.91% |
7,813
-31
| -0.4% | -$3.95K |
|
35
World Kinect Corp
WKC
$1.97B
| $1.05M | 0.9% |
+40,701
| New | +$1M |
|
|
36
Encompass Health
EHC
$11B
| $967K | 0.83% |
+19,622
| New | +$1.06M |
|
37
Tandem Diabetes Care
TNDM
$1.34B
| $935K | 0.8% |
9,448
-30
| -0.3% | -$2.39K |
|
38
8x8 Inc
EGHT
$328M
| $922K | 0.79% |
57,639
-47,940
| -45% | -$762K |
|
39
Charles River Laboratories
CRL
$12.6B
| $911K | 0.78% |
5,226
-35
| -0.7% | -$5.59K |
|
40
Knight Transportation
KNX
$11.5B
| $910K | 0.78% |
21,822
-65
| -0.3% | -$2.48K |
|
41
Magnachip Semiconductor
MX
$134M
| $888K | 0.76% |
86,247
-771
| -0.9% | -$8.59K |
|
42
Silicon Motion
SIMO
$8.36B
| $847K | 0.73% |
17,362
-311
| -2% | -$13.8K |
|
43
ANI Pharmaceuticals
ANIP
$1.82B
| $811K | 0.69% |
25,070
| – | – |
|
44
Ameris Bancorp
ABCB
$5.97B
| $767K | 0.66% |
32,532
+15,195
| +88% | +$357K |
|
45
Insperity
NSP
$1.95B
| $734K | 0.63% |
+11,335
| New | +$567K |
|
46
Paycom
PAYC
$8.15B
| $714K | 0.61% |
2,305
-1,506
| -40% | -$401K |
|
|
VRTU
47
DELISTED
Virtusa Corporation
VRTU
| $690K | 0.59% |
21,235
+8,262
| +64% | +$256K |
|
48
CALL
Boyd Gaming
BYD
$6.13B
| $633K | 0.54% |
30,300
-9,700
| -24% | -$177K |
|
49
CRISPR Therapeutics
CRSP
$5.17B
| $628K | 0.54% |
8,552
-43
| -0.5% | -$2.51K |
|
50
StoneCo
STNE
$2.72B
| $612K | 0.52% |
15,777
-67
| -0.4% | -$1.95K |
|
Similar funds
KA
DEA
EAN
PIP
SC
L
LB
ACM
1492 Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, 1492 Capital Management held 99 positions worth $117M, up 40% from $83.5M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
1492 Capital Management's Q2 2020 filing shows 19 new, 13 increased, 46 reduced and 14 closed positions. Its largest new stake was Roth CH Acquisition I Co. Unit: 213,860 shares worth $2.15M. The largest sale was KB Home, an estimated $1.22M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 35% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- 1492 Capital Management's largest Q2 2020 buy was Roth CH Acquisition I Co. Unit: 213,860 shares worth $2.15M.
- 1492 Capital Management added most to TriState Capital Holdings, Inc. in Q2 2020, an estimated $730K increase.
- 1492 Capital Management's biggest Q2 2020 reduction was NeoGenomics, cutting an estimated $1.06M.
- 1492 Capital Management fully exited KB Home in Q2 2020, selling an estimated $1.22M.
- 1492 Capital Management's ten largest holdings make up 42% of its $117M portfolio in Q2 2020.
- 1492 Capital Management opened 19 new positions and closed 14 in Q2 2020.
- 1492 Capital Management's portfolio value rose 40% quarter-over-quarter to $117M.
Based on 1492 Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.